RT @RESTOREhorizon: #6_WorkingGroup: #preclinical development of #advancedtherapies! At #RESTOREkickoff we will discuss topics such as clin…
#6_WorkingGroup: #preclinical development of #advancedtherapies! At #RESTOREkickoff we will discuss topics such as clinical relevance, suitability for screening and toxicity of #invitro and #invivo models and of course, regulatory acceptance. @fet_eu https
RT @CGTCatapult: It is important to be aware of both scientific issues and regulatory mechanisms to ensure successful product development. This paper discusses European regulatory mechanisms open to developers #Regualtion #PreClinical #NonClinicalSafety -
It is important to be aware of both scientific issues and regulatory mechanisms to ensure successful product development. This paper discusses European regulatory mechanisms open to developers #Regualtion #PreClinical #NonClinicalSafety - https://t.co/syeA
RT @CGTCatapult: There are several regulatory mechanisms available to developers to support cell and gene therapy development. These method…
There are several regulatory mechanisms available to developers to support cell and gene therapy development. These methods are discussed in this paper co-written by the @CGTCatapult pre-clinical safety team #Regulation #PreClinicalSafety - https://t.co/Ci
The diversity of cell-based medicinal products requires bespoke development at all stages – find out about #preclinical development of products for European markets in this paper co-written by the @CGTCatapult pre-clinical safety team - https://t.co/tZDpcS
RT @CGTCatapult: What regulatory mechanisms are open to developers to aid successful cell and gene therapy development in Europe? Find out…
RT @CGTCatapult: Are you developing cell-based medicinal products for European markets? Find out about the regulatory mechanisms open to de…
RT @CGTCatapult: What regulatory mechanisms are open to developers to aid successful cell and gene therapy development in Europe? Find out…
What regulatory mechanisms are open to developers to aid successful cell and gene therapy development in Europe? Find out in this paper co-written by the @CGTCatapult's pre-clinical safety team. #Regulation #PreClinical #PreClinicalSafety - https://t.co/KT
Are you developing cell-based medicinal products for European markets? Find out about the regulatory mechanisms open to developers in this paper co-written by the @CGTCatapult pre-clinical safety team #development #preclinical #preclinicalsafety - https://